Compugen (Israeli company)
http://dbpedia.org/resource/Compugen_(Israeli_company) an entity of type: Thing
Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competi
rdf:langString
rdf:langString
Compugen (Israeli company)
rdf:langString
Compugen Ltd.
rdf:langString
Compugen
rdf:langString
Compugen Ltd.
xsd:integer
1119774
xsd:integer
34046261
xsd:integer
1110509234
rdf:langString
Amir Natan
rdf:langString
Eli Mintz
rdf:langString
Simchon Faigler
rdf:langString
rdf:langString
Paul Sekhri
rdf:langString
Compugen logo.gif
rdf:langString
US$ -8.5 million ()
rdf:langString
US$ -8.7 million ()
rdf:langString
US$ 53 thousand ()
rdf:langString
CGEN
rdf:langString
NASDAQ:CGEN
rdf:langString
Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competitors.
xsd:nonNegativeInteger
18324
xsd:gYear
1993
<usDollar>
-8500000.0
<usDollar>
-8700000.0
<usDollar>
53000.0